Association of daily body temperature, white blood cell count, and C-reactive protein with mortality and persistent bacteremia in patients with Staphylococcus aureus bacteremia: a post-hoc analysis of the CAMERA2 randomized clinical trial

• Published in: Open forum infectious diseases Vol. 12; no. 2; p. ofaf063
• Main Authors: Ong, Sean W X, Daneman, Nick, Davis, Joshua S, Tong, Steven Y C, Lye, David C, Yahav, Dafna, Sud, Archana, Robinson, J Owen, Nelson, Jane, Archuleta, Sophia, Roberts, Matthew A, Cass, Alan, Paterson, David L, Foo, Hong, Paul, Mical, Guy, Stephen D, Tramontana, Adrian R, Walls, Genevieve B, McBride, Stephen, Bak, Narin, Ghosh, Niladri, Rogers, Benjamin A, Ralph, Anna P, Davies, Jane, Ferguson, Patricia E, Dotel, Ravindra, McKew, Genevieve L, Gray, Timothy J, Holmes, Natasha E, Smith, Simon, Warner, Morgyn S, Kalimuddin, Shirin, Young, Barnaby E, Runnegar, Naomi, Andresen, David N, Anagnostou, Nicholas A, Chatfield, Mark D, Cheng, Allen C, Fowler, Vance G, Howden, Benjamin P, Meagher, Niamh, Price, David J, van Hal, Sebastiaan J, Sullivan, Matthew V N O
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 01.02.2025
• Subjects: Diagnostic Methods and Tools; risk stratification; white blood cell; staphylococcus aureus bacteremia; MRSA; c-reactive protein
• ISSN: 2328-8957; 2328-8957
• DOI: 10.1093/ofid/ofaf063

Classification of patients with bacteremia as complicated versus uncomplicated is based on a combination of clinical and microbiologic variables. Whether daily body temperature and common laboratory tests such as C-reactive protein (CRP) and white blood cell (WBC) can improve risk stratification algorithms is unclear. We conducted a post hoc secondary analysis of the CAMERA2 trial, which enrolled hospitalized adult patients with methicillin-resistant bacteremia and prospectively collected daily body temperature and peripheral blood WBC and CRP. We evaluated the prognostic relevance of each parameter by calculating crude and adjusted odds ratios for 90-day all-cause mortality comparing patients with the abnormal parameter of interest versus those with normal parameters on each day of illness. A total of 345 patients were included in this analysis, of whom 63 (18.3%) died within 90 days. Fever (body temperature ≥38.0 °C) was associated with increased odds of 90-day mortality from day 4 and onwards. Fever later in the illness course was associated with higher adjusted odds of mortality (8.78; 95% confidence interval, 2.78-27.7 on day 7 vs adjusted odds ratio 3.70; 95% CI, 1.58-8.67 on day 4). In contrast, CRP and abnormal WBC count did not demonstrate a consistent or temporal association with mortality. Persistent fever after 72 hours is associated with increased mortality in patients with methicillin-resistant bacteremia, supporting recommendations that this should be kept as a criterion for classifying patients as either "high-risk" or "complicated." Within this dataset, there was limited additional predictive value in WBC or CRP.